Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

MS Research Roundup: September 29, 2014
Construct Validity of the Four Square Step Test in Multiple Sclerosis.
Expected Value of Partial Perfect Information for the Disability Progression Efficacy of Teriflunomide and Fingolimod in the Treatment of Relapsing-Remitting Multiple Sclerosis.
MS Research Roundup: May 27, 2014
Short Term Reproducibility of a High Contrast 3-D Isotropic Optic Nerve Imaging Sequence in Healthy Controls.
JC Polyomavirus Abundance and Distribution in Progressive Multifocal Leukoencephalopathy (PML) Brain Tissue Implicates Myelin Sheath in Intracerebral Dissemination of Infection.
Efficacy of hematopoietic stem cell formultiple sclerosis, an evidence based meta-analysis.
Boosting CNS axon regeneration by circumventing limitations of natural cytokine signaling.
Evaluation of Methods for the Inclusion of Real World Evidence in Network Meta-Analysis - A Case Study in Multiple Sclerosis.
A review of Neuropharmacology Effects of Nigella sativa and Its Main Component, Thymoquinone.
Cost-Utility Analysis (cua) Of First-Line Disease-Modifying Treatments (DMT) Versus Best Supportive Care (Bsc) In Finnish Relapsing-Remitting Multiple Sclerosis (RRMS) Patients.
Understanding walking activity in multiple sclerosis: step count, walking intensity and uninterrupted walking activity duration related to degree of disability.
Astrocytic IL-6 Influences the Clinical Symptoms of EAE in Mice.
The Cost Burden of Switching Patients with Relapsing-Remitting Multiple Sclerosis from Glatiramer Acetate To Newly-Approved Disease Modifying Therapies.
Behavioral assessment of neuropathic pain, fatigue, and anxiety in experimental autoimmune encephalomyelitis (EAE) and attenuation by interleukin-10 gene therapy.
Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper.
Papers: 21 Aug 2015 - 28 Aug 2015
Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis.
The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update.
Novel Insights into the Multiple Sclerosis Risk Gene ANKRD55.
The association of IL-18 gene promoter polymorphisms and the levels of serum IL-18 on the risk of multiple sclerosis.
Icariin exerts estrogen-like activity in ameliorating EAE via mediating estrogen receptor β, modulating HPA function and glucocorticoid receptor expression.
AAN Review Supports Treating Symptoms of MS with Cannabis
Tbet or Continued RORγt Expression Is Not Required for Th17-Associated Immunopathology.
MicroRNAs targeting TGFβ signalling underlie the regulatory T cell defect in multiple sclerosis.

Pages